COMMUNIQUÉS West-GlobeNewswire

Tetra Bio-Pharma Responds to Shareholders
04/12/2018
“Tetra is Not a Cannabis Company” Says CEO Chamberland ORLEANS, Ontario, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc (“ Tetra ” or “ TBP ”), (TSX VENTURE: TBP) (OTCQB: TBPMF) - Recent news regarding Aphria [...]
Data for BeyondSpring’s Lead Asset, Plinabulin, for Chemotherapy-Induced Neutropenia (CIN) Prevention Shows Differentiated Profile Compared with G-CSF and Adds Additional Protection to G-CSF
04/12/2018
BeyondSpring Presented Latest Clinical Results at 2018 American Society of Hematology (ASH) Annual Meeting Plinabulin monotherapy is an equally effective single-dose-per cycle agent as pegfilgrastim, but with minimal [...]
Holding(s) in Company
04/12/2018
Holding(s) in Company December 4, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : Shire plc (LEI: [...]
Allscripts to present at the Citi 2018 Global Healthcare Conference
04/12/2018
CHICAGO, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) today announced that certain members of its management team will present at the Citi 2018 Global Healthcare Conference in New York, NY on Thursday, [...]
Agility Health Subsidiaries File Notice of Intention to Make a Proposal Under the Bankruptcy and Insolvency Act (Canada)
04/12/2018
HAMILTON, Ontario, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV: AHI) (“ Agility Health ” or “ Company ”) announces that on December 3, 2018, four of the Company’s operating subsidiaries; Ontario [...]
VALNEVA to Conduct Investor and Partnering Meetings During the 37th Annual J.P. Morgan Healthcare Conference
04/12/2018
Valneva to Conduct Investor and Partnering Meetings During the 37 th Annual J.P. Morgan Healthcare Conference Saint-Herblain (France), December 4, 2018 - Valneva SE ("Valneva"), a biotech company developing and [...]
VALNEVA rencontrera investisseurs et partenaires potentiels lors de la J.P. Morgan Healthcare Conference
04/12/2018
Valneva rencontrera investisseurs et partenaires potentiels lors de la J.P. Morgan Healthcare Conference Saint-Herblain (France), 4 décembre 2018 - Valneva SE ("Valneva"), société de biotechnologie développant et [...]
Innovate Biopharmaceuticals Enters into a Collaboration with Massachusetts General Hospital and Announces Capital Update for the Celiac Disease Clinical Program and its NASH Development Strategy on December 17, 2018
04/12/2018
-- Announces collaboration in high unmet need Alcoholic Liver Diseases (ALD), including severe alcoholic hepatitis, with novel gut-specific, clinical-stage asset, larazotide acetate -- Investor update on capital plan [...]
CAPS® Expands National Footprint, Opens New 503B Compounding Outsourcing Facility in Phoenix
04/12/2018
New facility brings nearly 400 jobs and the latest engineering and technology in sterile compounding to the western U.S. IRVINE, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Central Admixture Pharmacy Services, Inc. (CAPS [...]
Claus Frisenberg Pedersen, CCO in Oncology Venture buys shares in the Company
04/12/2018
Company Announcement Claus Frisenberg Pedersen, CCO in Oncology Venture buys shares in the Company Hoersholm, Denmark – December 4, 2018 – Oncology Venture A/S (OV:ST) announces that CCO Claus Frisenberg Pedersen has [...]
The Alliance for Regenerative Medicine Announces 2019 Cell & Gene Therapies State of the Industry Briefing
04/12/2018
WASHINGTON, D.C., Dec. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapies and broader [...]
Peter Buhl Jensen, CEO in Oncology Venture buys shares in the Company
04/12/2018
Company Announcement Peter Buhl Jensen, CEO in Oncology Venture buys shares in the Company Hoersholm, Denmark – December 4, 2018 – Oncology Venture A/S (OV:ST) announces that CEO Peter Buhl Jensen, through Buhl Krone [...]
Precipio Announces $1.2 Million Securities Purchase Agreement With Participation from Members of Its Board of Directors, and other Investors
04/12/2018
NEW HAVEN, Conn., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced today that it has entered into a $1.2 million Securities Purchase Agreement with several [...]
Translate Bio Expands Patent Portfolio with Newly Issued U.S. Patent Relating to Its Messenger RNA (mRNA) Therapeutics Platform (MRT™)
04/12/2018
Patent Supports Foundational Intellectual Property and Pioneering Work in Liver Delivery for mRNA Therapeutics LEXINGTON, Mass., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger [...]
Inspire Medical Systems, Inc. Announces Proposed Offering of Common Stock
04/12/2018
MINNEAPOLIS, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Admera Health Adds Clinical Genomics Expert, Dr. Ruben Bonilla-Guerrero, to Management Team
04/12/2018
SOUTH PLAINFIELD, N.J., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Admera Health, a molecular diagnostic company, welcomes Dr. Ruben Bonilla-Guerrero as Medical Director to the company. Ruben Bonilla-Guerrero obtained his M.D. [...]
New Proximity Systems Open-Arm Cabinet Meets Space Constraints of Shrinking Patient Rooms
04/12/2018
Flexible workstation mount is ergonomically designed to improve ability of hospital staff to interact with patients TOMBALL, Texas, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Proximity Systems, Inc., the leading provider of [...]
Cellectar Initiates Cohort 6 of Phase 1b Trial Evaluating CLR 131 in Relapsed/Refractory Multiple Myeloma
04/12/2018
Patient enrolled at highest fractionated two-dose regimen to date FLORHAM PARK, N.J., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the [...]
Ritter Pharmaceuticals Reaches Halfway Mark for Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance
04/12/2018
Full Enrollment on Target for Q2 2019 with Data Readout Expected in the Second Half of 2019 LOS ANGELES, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “ [...]

Pages